About this trial
Pilot, prospective, mono-center study conducted in a population of healthy participants (free of cancer) for the analytical validation of circulating DNA analysis methods. The participants are employees of the institution. Their recruitement is carried out via internal posting (intranet and bulletin boards). The study participation will be strictly voluntary and without consequences on the professional situation of the participants.
Eligibility criteria
Qualifiers
1 Adult volunteer (≥ 18 y.o.)
2 Participant free of cancer
3 Participant belonging to the personnel of Oncopole Claudius Regaud (IUCT-O) institution
4 Participant affiliated to a Social Health Insurance in France
Disqualifiers
1 Participant presenting with an associated pathology potentially preventing the adequate conduct of the study procedure
2 Participant presenting with a contra-indication to blood draw
3 Participant who reports to the investigator team
4 Participant who has forfeited his/her freedom bu administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice)
Trial design
Treatments tested in this trial
- 1 single blood draw after in the inclusion of the participant in the study (Up to 30 mL).
Treatment groups
Sponsors and collaborators
Institut Claudius Regaud
Lead sponsor
Sophia Genetics SAS
Collaborator